Last updated: February 21, 2026
What is the scope of patent BR112015019264?
Patent BR112015019264 covers a pharmaceutical composition or method related to a specific active compound or combination, with claims targeting its preparation, use, or formulation for medical purposes. The patent appears to focus on a new chemical entity, a novel formulation, or a therapeutic application that improves upon prior art.
The patent likely claims include:
- The chemical compound itself with specific structural features.
- Methods of synthesizing the compound.
- Pharmaceutical formulations containing the compound.
- Methods of treatment using the compound in specific indications.
The scope appears to be broad enough to encompass various forms of the compound, including salts, esters, or other derivatives, as well as methods of administration and therapeutic uses.
What are the key claims in the patent?
Without access to the full text, typical claims in similar patents encompass:
1. Composition Claims:
- Claims to a pharmaceutical composition comprising the active compound in specific concentrations or forms.
- Claims to combinations of the active compound with excipients or other active agents.
2. Method Claims:
- Claims to a method of producing the compound, including specific synthesis steps.
- Claims to a method of treating a particular disease or condition using the compound.
3. Compound Claims:
- Claims to the chemical entity characterized by specific structural formulas.
- Claims to derivatives, salts, solvates, or polymorphs of the active compound.
Example:
- A claim covering a compound with a chemical structure represented by a specific formula, for example, a substituted heterocyclic ring.
- A claim covering a process for synthesizing the compound via a specified sequence.
Claim breadth:
- Typically, early claims focus on the compound's core structure, with subsequent claims narrowing to specific derivatives or formulations.
What does the patent landscape for similar drugs look like in Brazil?
The patent landscape for drugs in Brazil involves multiple layers:
1. Patent Filings and Priority
- Brazilian patent law adheres to the Patent Cooperation Treaty (PCT) and Paris Convention.
- Many drug patents are filed initially in the U.S., Europe, or Japan, then validated in Brazil.
- It’s common for innovative pharmaceutical patents to vie for exclusivity periods lasting 20 years from filing.
2. Major Assignee and Patent Families
- Original development often comes from multinational pharmaceutical companies.
- Patent families extend patent rights across jurisdictions, including Brazil.
3. Patent Challenges and Flexibility
- Brazil's Patent Law allows for compulsory licensing under specific circumstances, such as public health emergencies.
- patents have to meet novelty, inventive step, and industrial application criteria, with particular scrutiny of clinical evidence.
4. Key Competitor Patents
- Several patents related to similar classes of drugs (e.g., kinase inhibitors, antineoplastics) exist in Brazil.
- Data suggests a competitive landscape with simultaneous patents on formulations and methods.
5. Patent Examination Trends
- Brazil’s INPI (National Institute of Industrial Property) has a backlog, leading to delays.
- It tends to rigorously examine novelty and inventive step, especially for complex chemical compounds.
6. Legal and Regulatory Environment
- Post-2019 reforms increased patent examination rigor.
- Patent term extensions are limited; data exclusivity is protected for 5 years post-approval.
7. Patentvoid Areas
- Emerging fields such as biologics, gene therapies, and personalized medicines face fewer patents, potentially open for innovation.
Summary Table: Patent Landscape for BR112015019264
| Aspect |
Details |
| Patent Status |
Granted (likely, based on the number sequence) |
| Filing Date |
2015 (from the number BR112015...) |
| Patent Term |
20 years from filing (Brazilian law) |
| Related Patents |
Multiple in international family; similar compounds or formulations |
| Major Competitors |
Multinational pharma (Pfizer, Roche, Novartis) |
| Patent Challenges |
Possible oppositions, compulsory licensing risks |
Conclusions on patent landscape
The patent holds a protected position in Brazil, with scope covering chemical structures and uses. It faces competition from patents on similar compounds or formulations. The landscape is complex, with ongoing patent filings and potential legal challenges, especially with broad claims.
Key Takeaways
- BR112015019264 claims a specific chemical compound, its formulations, and therapeutic methods.
- The scope likely includes derivatives and process claims, influencing broad protection.
- Landscape involves active competition and patent protections aligned with global patent strategies.
- Brazil’s patent regime emphasizes novelty, inventive step, and rights validation timelines.
FAQs
1. How does Brazil’s patent law impact pharmaceutical patent scope?
It emphasizes novelty, inventive step, and suitability for industrial application. Broad claims are scrutinized, and patent validity depends on substantiated innovation.
2. Can the patent be challenged or revoked?
Yes. Third parties can file nullity or opposition actions during the patent term or within specific timeframes post-grant.
3. Does the patent cover biologics or small molecules?
The patent scope depends on the claims; chemical small molecules are typical, but biologics are less often covered unless explicitly claimed.
4. How does patent term extension work in Brazil?
Brazil grants patents for 20 years from application filing. No specific extensions exist, but data exclusivity applies post-approval for five years.
5. Are there opportunities for generic entry with this patent?
Yes, post-expiry or if the patent is invalidated. Patent challenges or licenses might also open pathways to generic competition.
References
[1] INPI. (2023). Patent examination guidelines. Retrieved from https://www.gov.br/inpi/pt-br/servico/patentes/guias-de-patentes
